Copyright
©The Author(s) 2022.
World J Hepatol. Jun 27, 2022; 14(6): 1142-1149
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1142
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1142
Table 1 General characteristics of cases and controls
| Characteristics | Cases, n = 39 | Controls, n = 78 |
| Age, mean ± SD | 55.23 ± 13.51 | 55.32 ± 13.65 |
| Sex, males (%) | 26 (66.7) | 52 (66.7) |
| Race, n (%) | ||
| Caucasian | 31 (79.5) | 45 (57.7) |
| African American | 3 (7.7) | 11 (14.1) |
| Hispanic | 3 (7.7) | 14 (17.9) |
| Asian | 0 (0.0) | 2 (2.6) |
| Other/unknown | 2 (5.1) | 6 (7.7) |
| Presence of | ||
| Diabetes, n (%) | 17 (43.6) | 15 (19.2) |
| Hypertension, n (%) | 23 (59) | 30 (38.5) |
| Obesity, n (%) | 14 (35.9) | 28 (35.9) |
| Congestive heart failure, n (%) | 3 (7.7) | 6 (7.7) |
| Chronic kidney disease or hemodialysis, n (%) | 14 (35.9) | 8 (10.3) |
- Citation: Shafiq M, Gibson C. Clinical outcomes of coronavirus disease 2019 in liver transplant recipients. World J Hepatol 2022; 14(6): 1142-1149
- URL: https://www.wjgnet.com/1948-5182/full/v14/i6/1142.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i6.1142